Clinical Trial Detail


Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at :

NCT ID NCT03872388
Title Atorvastatin in Treating Patients With Stage IIb-III Triple Negative Breast Cancer Who Did Not Achieve a Pathologic Complete Response After Receiving Neoadjuvant Chemotherapy
Recruitment Recruiting
Gender both
Phase Phase II
Variant Requirements No
Sponsors M.D. Anderson Cancer Center

triple-receptor negative breast cancer


Atorvastatin + Capecitabine


Age Groups: senior | adult
Covered Countries USA

Facility Status City State Zip Country Details
Banner - MD Anderson Cancer Center Not yet recruiting Gilbert Arizona 85234 United States Details
Banner - MD Anderson Cancer Center -Northern Colorado Not yet recruiting Greeley Colorado 80631 United States Details
Piedmont Healthcare Not yet recruiting Atlanta Georgia 30309 United States Details
Cooper Hospital University Medical Center Recruiting Camden New Jersey 08103 United States Details
M D Anderson Cancer Center Recruiting Houston Texas 77030 United States Details
*Shaded cells indicate that there was no data available from for the field